Skip to content

Homoeopathic treatment of respiratory tract infection in children

Feasibility testing of a double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in pediatric upper respiratory tract infection

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028743
Enrollment
60
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

dosage and repetition depending upon the individual requirement of the cases. Medicines like antibiotics, glucocorticosteroids and antiallergics will not be permitted. All medicines will be procured f
dosage and repetition depending upon the individual requirement of the cases. Medicines like antibiotics, glucocorticosteroids and antiallergics will not be permitted. Route of administration of medic

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of age group 1-11 years and of either sex 2. Clinical signs and symptoms of an URTI with a duration of >= 24 hours with or without fever >=37.5áµ?C 3. At least 1 of 3 types of URTI symptoms â?? nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), and cough (ordinary cough without suspicion of acute lower respiratory tract disease) 4. At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney, or less active. 5. Literate guardians or attendants capable of understanding and filling the questionnaire and providing written informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe or complicated course of URTI 2. Signs of acute LRTI 3. COVID-19 positive cases as diagnosed by RT-PCR method 4. Current symptoms mainly induced by other acute ENT diseases 5. Daily use of antibiotics, steroids and cytotoxic agents 6. Diagnosed cases of unstable developmental, mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 7. Immune-compromised state, and 8. Already undergoing homoeopathic or other modes of treatment for URTI.

Design outcomes

Primary

MeasureTime frame
Wisconsin Upper Respiratory Symptom Survey (WURSS-21) scoresTimepoint: At baseline, 4th (±1) day, 8th (±1) day, and 15th (±2) days

Secondary

MeasureTime frame
Canadian Acute Respiratory Illness and Flu Scale (CARIFS) questionnaire scoresTimepoint: At baseline, 4th (±1) day, 8th (±1) day, and 15th (±2) days;URI symptom severity scale (URI-SSS) scoresTimepoint: At baseline, 4th (±1) day, 8th (±1) day, and 15th (±2) days

Countries

India

Contacts

Public ContactProf Dr Shyamal Kumar Mukherjee

D. N. De Homoeopathic Medical College and Hospital

ganguly.subhasish@rediffmail.com9007263548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026